{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T17:49:39Z","timestamp":1789148979012,"version":"build-2803163510"},"reference-count":10,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,4,12]],"date-time":"2021-04-12T00:00:00Z","timestamp":1618185600000},"content-version":"vor","delay-in-days":101,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Translational Autoimmunity"],"published-print":{"date-parts":[[2021]]},"DOI":"10.1016\/j.jtauto.2021.100099","type":"journal-article","created":{"date-parts":[[2021,4,16]],"date-time":"2021-04-16T11:03:58Z","timestamp":1618571038000},"page":"100099","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"special_numbering":"C","title":["Successful treatment of ulcerated pyoderma gangrenosum with baricitinib, a novel JAK inhibitor"],"prefix":"10.1016","volume":"4","author":[{"given":"Morton","family":"Scheinberg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis Ant\u00f4nio","family":"Machado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luiz Guilherme","family":"M Castro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sineida Berbert","family":"Ferreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nilceo","family":"Michalany","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.jtauto.2021.100099_bib1","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1177\/0141076814534407","article-title":"Management of pyoderma gangrenosum","volume":"107","author":"Teagle","year":"2014","journal-title":"J.\u00a0R. Soc. Med."},{"key":"10.1016\/j.jtauto.2021.100099_bib2","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1111\/bjd.15226","article-title":"Autoinflammation in pyoderma gangrenosum and its syndromic form(pyoderma gangrenosum) acne and suppurative hidradenitis)","volume":"176","author":"Marzano","year":"2017","journal-title":"Br. J. Dermatol."},{"issue":"4","key":"10.1016\/j.jtauto.2021.100099_bib3","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1001\/jamadermatol.2017.5980","article-title":"Diagnostic criteria of ulcerative pyoderma gangrenosum: a delphi consensus of international experts","volume":"154","author":"Maverakis","year":"2018","journal-title":"JAMA Dermatol"},{"issue":"3","key":"10.1016\/j.jtauto.2021.100099_bib4","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/s40257-017-0251-7","article-title":"Pyoderma gangrenosum: an update on pathophysiology, diagnosis and treatment","volume":"18","author":"Alavi","year":"2017","journal-title":"Am. J. Clin. Dermatol."},{"issue":"3","key":"10.1016\/j.jtauto.2021.100099_bib5","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1080\/09546634.2018.1506083","article-title":"Biologic and small-molecule medications in the management of pyoderma gangrenosum","volume":"30","author":"McKenzie","year":"2019","journal-title":"J.\u00a0Dermatol. Treat."},{"issue":"3","key":"10.1016\/j.jtauto.2021.100099_bib6","first-page":"5","article-title":"Janus kinase inhibitors: a review of their emerging applications in dermatology","volume":"23","author":"Cinats","year":"2018","journal-title":"Skin Therapy Lett"},{"key":"10.1016\/j.jtauto.2021.100099_bib7","doi-asserted-by":"crossref","DOI":"10.1136\/annrheumdis-2020-217271","article-title":"Steroid-resistant sarcoidosis treated with baricitinib","author":"Scheinberg","year":"2020","journal-title":"Ann. Rheum. Dis."},{"issue":"3","key":"10.1016\/j.jtauto.2021.100099_bib8","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1080\/1744666X.2018.1438269","article-title":"Pyoderma gangrenosum: a review of pathogenesis and treatment","volume":"14","author":"Ahn","year":"2018","journal-title":"Expet Rev. Clin. Immunol."},{"issue":"6","key":"10.1016\/j.jtauto.2021.100099_bib9","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1016\/j.jaad.2019.09.032","article-title":"Pyoderma Gangrenosum in hematological malignancies","volume":"82","author":"Montagnon","year":"2020","journal-title":"J.\u00a0Am. Acad. Dermatol."},{"key":"10.1016\/j.jtauto.2021.100099_bib10","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1007\/s10067-020-05253-7","article-title":"Rheumatoid arhtirtis and pyoderma gangrenosum : a population-based case control study","volume":"40","author":"Kridrin","year":"2021","journal-title":"Clin. Rheumatol."}],"container-title":["Journal of Translational Autoimmunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589909021000198?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589909021000198?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T23:33:12Z","timestamp":1762903992000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589909021000198"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021]]},"references-count":10,"alternative-id":["S2589909021000198"],"URL":"https:\/\/doi.org\/10.1016\/j.jtauto.2021.100099","relation":{},"ISSN":["2589-9090"],"issn-type":[{"value":"2589-9090","type":"print"}],"subject":[],"published":{"date-parts":[[2021]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Successful treatment of ulcerated pyoderma gangrenosum with baricitinib, a novel JAK inhibitor","name":"articletitle","label":"Article Title"},{"value":"Journal of Translational Autoimmunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtauto.2021.100099","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"100099"}}